UroSens is developing diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. The Company has a worldwide exclusive license, from Cancer Research Technology, for the exploitation of MCM cancer biomarkers in the d...Show all
Company (Alive / Active)
Phone: +44 (0)1223 836 556
Babraham Research Campus
Babraham
Cambridge, CB22 3AT
England, United Kingdom
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Name | Firm |
---|---|
Login to see details | Esperante |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|